Just a quick bit of good news: four patents of the key AIDS/HIV drug tenofovir disoproxil fumarate have been revoked on grounds of prior art. This is great news for developing nations where lower prices on these drugs could save thousands of lives. [Via Slashdot]
Of course, Gilead (the company whose patents have been revoked) are vowing to fight their corner; after all, life is a wonderful thing, but it must always come second to profit.
Wired has a report on the growing field of